Capstan Therapeutics, Inc. has raised $227.0M in total funding. The most recent round was Series B.
Capstan Therapeutics, Inc. is headquartered in San Diego, CA.
Co-founded by Drew Weissman, the 2023 Nobel Prize winner in Physiology or Medicine for mRNA vaccine research, alongside CAR-T pioneer Carl June; the company was later acquired by AbbVie.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.